Literature DB >> 12363004

Stability, persistence, and evolution of plasmid-encoded VanA glycopeptide resistance in enterococci in the absence of antibiotic selection in vitro and in gnotobiotic mice.

Pål J Johnsen1, Gunnar S Simonsen, Orjan Olsvik, Tore Midtvedt, Arnfinn Sundsfjord.   

Abstract

Long-term persistence of VanA glycopeptide-resistant enterococci (GRE) has been observed in the absence of antibiotic selection. In the present study, we examined fitness parameters of a glycopeptide-susceptible Enterococcus faecium parent strain and its plasmid-mediated, VanA-resistant derivative before and after 1,000 generations in serial transfer broth cultures with or without antibiotic selection. With the exception of the vanA-containing plasmid, the strains were otherwise isogenic. The stability of the plasmid-encoded vanA resistance determinant was also investigated in vitro and in gnotobiotic mice. Competition experiments revealed that GRE with newly acquired VanA resistance had a 4% reduction in fitness relative to their susceptible parental counterpart. The relative difference in competitive fitness between resistant and susceptible strains was not significantly changed after 1,000 generations. Environmental adaptation was observed in all strains and exceeded the biological cost of resistance. Thus, the evolved VanA-resistant E. faecium populations out-numbered their unevolved ancestral susceptible E. faecium strain in mixed cultures, but remained less competitive than the evolved parent. The glycopeptide resistance determinant was similarly stably maintained during long-term colonization in gnotobiotic mice without antibiotic selection. In vivo vanA plasmid transfer was observed. The results suggest that environmental adaptation, in vivo gene transfer, and plasmid maintenance system(s) favor long-term VanA GRE persistence without antibiotic selection and compensate for the biological costs of possessing the resistance genes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12363004     DOI: 10.1089/107662902760326869

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  26 in total

1.  Evidence of antibiotic resistance gene silencing in Escherichia coli.

Authors:  Virve I Enne; Anne A Delsol; John M Roe; Peter M Bennett
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Prevalence, persistence, and molecular characterization of glycopeptide-resistant enterococci in Norwegian poultry and poultry farmers 3 to 8 years after the ban on avoparcin.

Authors:  M Sørum; P J Johnsen; B Aasnes; T Rosvoll; H Kruse; A Sundsfjord; G S Simonsen
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

Review 3.  Antibiotic resistance and its cost: is it possible to reverse resistance?

Authors:  Dan I Andersson; Diarmaid Hughes
Journal:  Nat Rev Microbiol       Date:  2010-03-08       Impact factor: 60.633

4.  Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci.

Authors:  Elizabeth M Moritz; Paul J Hergenrother
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-26       Impact factor: 11.205

5.  Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host.

Authors:  Taradon Luangtongkum; Zhangqi Shen; Virginia W Seng; Orhan Sahin; Byeonghwa Jeon; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

6.  Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiota.

Authors:  Burcu Tepekule; Pia Abel Zur Wiesch; Roger D Kouyos; Sebastian Bonhoeffer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-30       Impact factor: 11.205

7.  Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci.

Authors:  Marie-Laure Foucault; Florence Depardieu; Patrice Courvalin; Catherine Grillot-Courvalin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-10       Impact factor: 11.205

8.  Transfer of plasmid-mediated CTX-M-9 from Salmonella enterica serotype Virchow to Enterobacteriaceae in human flora-associated rats treated with cefixime.

Authors:  S Faure; A Perrin-Guyomard; J M Delmas; P Chatre; M Laurentie
Journal:  Antimicrob Agents Chemother       Date:  2009-11-09       Impact factor: 5.191

Review 9.  Acquired inducible antimicrobial resistance in Gram-positive bacteria.

Authors:  Scott T Chancey; Dorothea Zähner; David S Stephens
Journal:  Future Microbiol       Date:  2012-08       Impact factor: 3.165

10.  Diverse tetracycline resistance genotypes of Megasphaera elsdenii strains selectively cultured from swine feces.

Authors:  Thaddeus B Stanton; Jennifer S McDowall; Mark A Rasmussen
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.